Stock listing
ALDVI Stock Price, News, Filings & Events — Advicenne Sa
Selected listing: ALDVI · EURONEXT · EUR · FR
This page tracks Advicenne Sa's ALDVI:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALDVI:EURONEXT. ALDVI:EURONEXT is the stock-level entry point for investors researching Advicenne Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Advicenne SA is a public company listed on the French market under the ticker ALDVI, with a market capitalization of approximately €26.16 million. The company focuses on developing innovative treatments for patients with rare kidney diseases. Advicenne aims to address unmet medical needs through its specialized pharmaceutical products.
- Ticker
- ALDVI:EURONEXT
- Asset type
- Stock
- Market cap
- $14.9M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Generic
- Exchange
- EURONEXT
- Currency
- EUR
Advicenne Sa ALDVI:EURONEXT stock context
This page tracks Advicenne Sa's ALDVI:EURONEXT listing on EURONEXT in EUR for FR, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ALDVI:EURONEXT. ALDVI:EURONEXT is the stock-level entry point for investors researching Advicenne Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Advicenne SA is a public company listed on the French market under the ticker ALDVI, with a market capitalization of approximately €26.16 million. The company focuses on developing innovative treatments for patients with rare kidney diseases. Advicenne aims to address unmet medical needs through its specialized pharmaceutical products.
Latest news from Advicenne Sa
Advicenne decides to withdraw its ADV7103 New Drug Application in the USA
August 31, 2026
Advicenne Announces the Reimbursement of Sibnayal® for the Treatment of dRTA in Spain
July 20, 2026
Advicenne: Net Revenue for the First Half of 2026 Driven by Reimbursement of Sibnayal® and Likozam® in France
July 16, 2026
Advicenne Announces the Unlimited Renewal of the Marketing Authorization for Sibnayal® in the United Kingdom
July 1, 2026
Advicenne secures its cash runway to Q2 2027 through a bond financing of a nominal amount of up to EUR3.8 million
June 23, 2026
Research Advicenne Sa
Advicenne Sa investor report
Review AI stock analysis and investor report context for ALDVI:EURONEXT.
Advicenne Sa company profile
View the public company page for Advicenne Sa on 6ix.
Advicenne Sa news
Read company news and market updates connected to Advicenne Sa.
Advicenne Sa investor events
Find investor webinars, events, and replay context for Advicenne Sa.
Alternate listings
3MM:GETTEX
DE · EUR
Alternate listing for Advicenne Sa; the primary context on this page is ALDVI:EURONEXT.
A2H8SU:LSX
DE · EUR
Alternate listing for Advicenne Sa; the primary context on this page is ALDVI:EURONEXT.
A2H8SU:LS
DE · EUR
Alternate listing for Advicenne Sa; the primary context on this page is ALDVI:EURONEXT.
3MM:FWB
DE · EUR
Alternate listing for Advicenne Sa; the primary context on this page is ALDVI:EURONEXT.
3MM:DUS
DE · EUR
Alternate listing for Advicenne Sa; the primary context on this page is ALDVI:EURONEXT.
3MM:MUN
DE · EUR
Alternate listing for Advicenne Sa; the primary context on this page is ALDVI:EURONEXT.
ADVVF:OTC
US · USD
Alternate listing for Advicenne Sa; the primary context on this page is ALDVI:EURONEXT.
3MM:SWB
DE · EUR
Alternate listing for Advicenne Sa; the primary context on this page is ALDVI:EURONEXT.